SCARSDALE, N.Y., March 30 /PRNewswire/ -- Double Helix Consulting US, a division of London-based Double Helix Development group, today announced the appointment of Ann Stuchiner to the position of Vice President. Stuchiner joins a multidisciplinary team of highly experienced strategic pricing, reimbursement and market access consultants with extensive experience across the healthcare industry, which provide product commercialization services to firms in the pharmaceutical, biotechnology and medical device industries. DHC US provides services spanning the product lifecycle, including the following:
Drew Baker, President of Double Helix Consulting US, commented, "Ann complements our international market access, pricing and reimbursement capabilities through her vast experience in planning and implementing product development and launch strategies for the US market. Ann Stuchiner has led product planning initiatives in myriad therapeutic areas and has particular expertise in oncology, neurosciences, infectious disease, cardiometabolics, gastroenterology and pain. Her intimate knowledge of managed care market structure, formulary management, contracting strate
|SOURCE Double Helix Consulting US|
Copyright©2009 PR Newswire.
All rights reserved